Share
125 Posts.
lightbulb Created with Sketch. 269
clock Created with Sketch. 07/10/23
18:30
Share
Originally posted by Taureanbull:
↑
Over the last few weeks we have seen a 50% drop in our shareprice. Extraordinary destruction considering IMU just landed the deal of the century. In one quick and decisive move IMU jumped the queue to be in the front of the CarT race. Which incidentally included an approved batch of Azer-Cel from their newly acquired FDA approved manufacturing facility. Anybody who follows Biotechnology knows just how important this is. To gain any FDA drug approval it must be manufactured in an approved facility. Getting this approval can take several years . The FDA must approve everything including packaging, inserts and warnings, even the color layouts, color and design of pills. Just everything.
Expand
TB got to disagree. The prevailing force without any question, is the institutional shorters. Our careless chairman continues to feed them with new stock in return for their cash. The most recent effort yielded $35m cash for the Imugene bank balance, at a cost of several hundred million market cap, did you read that, several hundred million capital value, which anyone on the register already feels the pain of. Not only does he try to protect their identity, they enter the register via nominee accounts and then it’s difficult to see what goes on. One thing that is a certainty is that more than 2% of the short positions were closed at the time the recent new placement was done - think about that.. ie they were already short and were then hand fed more stock to close out. The decision from management to do this is a sackable offence requiring instant removal of whoever was stupid enough to allow it. Make no mistake, the hostility toward retail holders is from within, and on that note, it’s no wonder some have decided to sell once they have figured out what’s actually going on, and has been for some time.
